Patel Chem Specialities FY26 Annual Report: Revenue Up 31%, PAT at 12.55 Cr

Revenue Growth 20pctEbitda Margin CompressionRelated Party TransactionsResults View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-1.8%Reaction day

₹107.99

prior close

₹108.95

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-1.0%-0.8% vs market

Specialty Chemicals peers, median of 101sector+0.0%-1.8% vs sector

On the reaction day the stock moved 0.8 pts less than Nifty Microcap 250 and 1.8 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-1.8-1.0-0.8+0.0-1.8

Next day

-0.9-1.5+0.6-0.5-0.4

+1.9-0.9+2.8+0.4+1.5

-0.4-0.3-0.1+0.6-1.0

+3.7+0.1+3.6+0.6+3.1

+0.1+0.7-0.5+1.4-1.3

+0.9+0.3+0.6+1.0-0.1

15d

+2.7+1.0+1.8+1.3+1.5

+11.6-2.4+14.0-1.9+13.6

—————

UpDownMarket · Nifty Microcap 250Sector · Specialty Chemicals peers, median of 101Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Patel Chem Specialities filed its FY2025-26 Annual Report. Revenue grew 31.8% YoY to 139.08 crore; EBITDA rose 19.6% to 18.89 crore but margins compressed from 14.97% to 13.58%. PAT increased 18.8% to 12.55 crore. The company recently listed on BSE SME via a 58.80 crore IPO. Net worth nearly tripled to 99.50 crore post-IPO. ROE moderated to 12.62% from 29.85% due to enlarged equity base. AGM on September 25, 2026 includes approval for related party transactions up to 65 crore.

Likely market impact

Strong revenue growth post-IPO but margin pressure and lower ROE signal dilution effect from equity raise.